Pfizer (PFE) Earnings Date, Estimates & Call Transcripts $26.36 -0.29 (-1.07%) As of 10:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pfizer Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 4Before Market OpensEstimatedActual EPS (Oct. 29) $1.06 Beat By $0.42 Consensus EPS (Oct. 29) $0.64 Pfizer announced Q3 2024 earnings on October 29, 2024, reporting an EPS of $1.06, which beat analysts' consensus estimates of $0.64 by $0.42. Quarterly revenue rose 31.2% year-over-year to $17.70 billion, above analyst estimates of $14.92 billion. With a trailing EPS of $0.74 and a P/E Ratio of 35.61, Pfizer's earnings are expected to decrease -0.34% next year, from $2.94 to $2.93 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by PFE Upcoming EarningsPfizer's next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules, with a conference call scheduled for at 10:30 AM ET. Interested parties can register for or listen to the call. Get Pfizer Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pfizer and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPFE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PFE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Pfizer Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252$0.58$0.61$0.60 Q2 20252$0.55$0.60$0.58 Q3 20252$0.83$1.11$0.97 Q4 20252$0.66$0.82$0.74 FY 20258$2.62$3.14$2.88 Q1 20261$0.63$0.63$0.63 Q2 20261$0.61$0.61$0.61 Q3 20261$0.78$0.78$0.78 Q4 20261$0.85$0.85$0.85 FY 20264$2.87$2.87 $2.87 Pfizer Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/4/2025(Estimated)-------10/29/2024Q3 2024$0.64$1.06+$0.42$1.34$14.92B$17.70B7/30/2024Q2 2024$0.46$0.60+$0.14$1.19$12.96B$13.28B5/1/2024Q1 2024$0.56$0.82+$0.26$1.09$13.87B$14.88B1/30/2024Q4 2023-$0.19$0.10+$0.29$0.80$14.37B$14.25B10/31/2023Q3 2023-$0.32-$0.17+$0.15$0.08$13.77B$13.23B8/1/2023Q2 2023$0.57$0.67+$0.10$0.93$13.36B$12.73B5/2/2023Q1 2023$1.00$1.23+$0.23$1.49$16.49B$18.28B1/31/2023Q4 2022$1.03$1.14+$0.11$1.41$24.40B$24.30B Pfizer Earnings - Frequently Asked Questions When is Pfizer's earnings date? Pfizer has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on PFE's earnings history. What guidance has Pfizer issued on next quarter's earnings? Pfizer updated its FY 2024 earnings guidance on Wednesday, December, 18th. The company provided earnings per share (EPS) guidance of 2.750-2.950 for the period, compared to the consensus estimate of 2.930. The company issued revenue guidance of $61.0 billion-$64.0 billion, compared to the consensus revenue estimate of $62.9 billion. Did Pfizer beat their earnings estimates last quarter? In the previous quarter, Pfizer (NYSE:PFE) reported $1.06 earnings per share (EPS) to beat the analysts' consensus estimate of $0.64 by $0.42. Learn more on analysts' earnings estimate vs. PFE's actual earnings. How can I listen to Pfizer's earnings conference call? The conference call for Pfizer's latest earnings report can be listened to online. Listen to Conference Call How can I read Pfizer's conference call transcript? The conference call transcript for Pfizer's latest earnings report can be read online. Read Transcript How much revenue does Pfizer generate each year? Pfizer (NYSE:PFE) has a recorded annual revenue of $58.50 billion. How much profit does Pfizer generate each year? Pfizer (NYSE:PFE) has a recorded net income of $2.12 billion. PFE has generated $0.74 earnings per share over the last four quarters. What is Pfizer's price-to-earnings ratio? Pfizer (NYSE:PFE) has a trailing price-to-earnings ratio of 35.57 and a forward price-to-earnings ratio of 8.95. The price/earnings-to-growth ratio is 0.63. What is Pfizer's EPS forecast for next year? Pfizer's earnings are expected to decrease from $2.94 per share to $2.93 per share in the next year, which is a -0.34% change. More Earnings Resources from MarketBeat Related Companies JNJ Earnings Results ABBV Earnings Results MRK Earnings Results BMY Earnings Results ZTS Earnings Results RPRX Earnings Results JAZZ Earnings Results CORT Earnings Results PRGO Earnings Results SUPN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NYSE:PFE) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfizer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
